Treatment of cardiac conditions
- 专利权人:
- ZEALAND PHARMA A/S
- 发明人:
- LARSEN BJARNE DUE,HANSEN RIE SCHULTZ,FOSGERAU KELD,AXELSEN LENE,PETERSEN JORGEN SOBERG,PEDERSEN HENRIK DUELUND,SKOVGAARD MARIE,RIBER DITTE,MEIER EDDI,KJOELBYE ANNE LOUISE
- 申请号：
- NZ60116711
- 公开号：
- NZ601167A
- 申请日:
- 2011.01.20
- 申请国别(地区):
- NZ
- 年份:
- 2014
- 代理人:
- 摘要：
- The us of a glucagon-GLP-1 dual agonist being a positive inotropic agent in the preparation of a medicament for the treatment of heart disease or heart dysfunction.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- PROPHYLACTIC OR THERAPEUTIC AGENT FOR RETINAL DISEASES AND METHOD FOR PREVENTING OR TREATING RETINAL DISEASES, EACH COMPRISING JNK (C-JUN N-TERMINAL KINASE)-INHIBITING PEPTIDE, AND USE OF THE PEPTIDE
- PROPHYLACTIC OR THERAPEUTIC AGENTS FOR HEALTH DISEASES
- ANTIMICROBIAL PEPTIDES FOR TREATMENT OF INFECTIOUS DISEASES
- PROPHYLACTIC OR THERAPEUTIC AGENT FOR RETINAL DISEASE AND METHOD FOR PROPHYLAXIS OR THERAPY OF RETINAL DISEASE USING JNK (C-JUN AMINO-TERMINAL KINASE) - INHIBITORY PEPTIDE, AND USE OF THE PEPTIDE
- - Pharmaceutical compositions for preventing and treating of eye diseases comprising fusion protein of tissue permeable peptide and anti-VEGF agent
